Showing results (11-20 of 96) with videos related to
Sort By:
Pageof 10
Current Cardiology Reports|September 12, 2000
Inflammation and lipid-lowering treatmentC M Ballantyne, Y AbePreventive Cardiology|February 6, 2002
The evolving role of high-density lipoprotein in reducing cardiovascular riskC M Ballantyne, G R RangarajProgress in Cardiovascular Diseases|October 28, 1998
Defining specific goals of therapy in treating dyslipidemia in the patient with low high-density lipoprotein cholesterolL M Belalcazar, C M BallantyneJournal of Immunology (Baltimore, Md. : 1950)|December 1, 1996
Functions of domain 1 and 4 of vascular cell adhesion molecule-1 in alpha4 integrin-dependent adhesion under static and flow conditions are differentially regulatedY Abe, C M Ballantyne, C W SmithThe American Journal of Cardiology|October 6, 2000
Efficacy and safety of an extended-release formulation of fluvastatin for once-daily treatment of primary hypercholesterolemiaC M Ballantyne, J McKenney, B S TrippeThe American Journal of Cardiology|March 1, 2000
Strategies for implementing lipid-lowering therapy: pharmacy-based approachK K Birtcher, C Bowden, C M Ballantyne, et al.Archives of Internal Medicine|October 20, 1998
Maximizing the cost-effectiveness of lipid-lowering therapyT A Jacobson, J R Schein, A Williamson, et al.Journal of Lipid Research|July 7, 2000
Leukocyte CD11b expression is not essential for the development of atherosclerosis in miceN Kubo, W A Boisvert, C M Ballantyne, et al.Blood|August 1, 1992
Molecular cloning and analysis of in vivo expression of murine P-selectinW E Sanders, R W Wilson, C M Ballantyne, et al.The American Journal of Medicine|September 1, 2001
Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statinsT C Andrews, C M Ballantyne, J A Hsia, et al.Pageof 10